Literature DB >> 5101783

Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. I. Association of bone disease with potentially etiologic factors.

A E Fournier, W J Johnson, D R Taves, J W Beabout, C D Arnaud, R S Goldsmith.   

Abstract

The present study was prompted by the observation that, in patients with chronic renal failure being followed at this center, renal osteodystrophy developed almost exclusively in those who were treated by chronic hemodialysis at home rather than in our center. A systematic comparison was made between the 10 patients with roentgenographic evidence of the bone disease and 18 patients without demonstrable bone disease. The two groups were similar in age, sex, nature of renal disease, and duration of dialysis. The mean duration of kidney disease was almost 2 yr longer in the patients without bone disease than in those with bone disease. Other significant differences related to where the hemodialysis was performed and to the calcium concentration in the dialysate (6.0-7.4 mg/100 ml in the hospital and 4.9-5.6 mg/100 ml at home). If the unknown factors related to where the dialysis was performed were of no consequence, the major factor contributing to the production of bone disease observed in these patients was the use of a dialysate with a calcium concentration less than 5.7 mg/100 ml.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5101783      PMCID: PMC291967          DOI: 10.1172/JCI106529

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

Review 1.  Bone disease in uremia.

Authors:  S W Stanbury
Journal:  Am J Med       Date:  1968-05       Impact factor: 4.965

2.  Optimum calcium concentration of dialysis fluid for maintenance haemodialysis.

Authors:  A J Wing
Journal:  Br Med J       Date:  1968-10-19

3.  The course of secondary hyperparathyroidism during chronic hemodialysis.

Authors:  E Ritz; H E Franz; E Jahns
Journal:  Trans Am Soc Artif Intern Organs       Date:  1968

4.  Renal osteodystrophy in course of periodic dialysis for chronic uremia.

Authors:  D Kim; N H Bell; W Bundesen; P Putong; N M Simon; C Walker; F Del Greco
Journal:  Trans Am Soc Artif Intern Organs       Date:  1968

5.  Hard-water syndrome.

Authors:  R M Freeman; R L Lawton; M A Chamberlain
Journal:  N Engl J Med       Date:  1967-05-18       Impact factor: 91.245

6.  Prevalence of osteoporosis in high- and low-fluoride areas in North Dakota.

Authors:  D S Bernstein; N Sadowsky; D M Hegsted; C D Guri; F J Stare
Journal:  JAMA       Date:  1966-10-31       Impact factor: 56.272

7.  Hemodialysis: a successful therapy for chronic uremia.

Authors:  J P Pendras; R V Erickson
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

8.  Normal human serum fluoride concentrations.

Authors:  D R Taves
Journal:  Nature       Date:  1966-07-09       Impact factor: 49.962

9.  Changes in total and ultrafilterable plasma calcium and magnesium during hemodialysis.

Authors:  D A Ogden; J H Holmes
Journal:  Trans Am Soc Artif Intern Organs       Date:  1966

10.  The metabolic fate of vitamin D3-3H in chronic renal failure.

Authors:  L V Avioli; S Birge; S W Lee; E Slatopolsky
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

View more
  9 in total

1.  Dailysate calcium and plasma calcium fractions during and after haemodialysis.

Authors:  C Fuchs; M Brasche; U Donath-Wolfram; J Kubosch; E Quellhorst; F Scheler
Journal:  Klin Wochenschr       Date:  1975-01

2.  Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.

Authors:  P E Cordy
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

3.  Bone disease in hemodialysis patients with particular reference to the effect of fluoride.

Authors:  P E Cordy; R Gagnon; D R Taves; M Kaye
Journal:  Can Med Assoc J       Date:  1974-06-22       Impact factor: 8.262

4.  Study on the influence of dialysis with varying bath calcium concentrations on the different plasma calcium fractions.

Authors:  R Verberckmoes
Journal:  Klin Wochenschr       Date:  1972-05-01

5.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. II. Factors affecting serum immunoreactive parathyroid hormone.

Authors:  A E Fournier; C D Arnaud; W J Johnson; W F Taylor; R S Goldsmith
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

6.  Renal excretion of fluoride in renal failure and after renal transplantation.

Authors:  V Parsons; A A Choudhury; J A Wass; A Vernon
Journal:  Br Med J       Date:  1975-01-18

7.  Calcium uptake and phosphate removal during hemodialysis with variing dialysate calcium.

Authors:  F Skrabal; P Dittrich; F Gabl
Journal:  Klin Wochenschr       Date:  1974-05-15

8.  Intestinal calcium absorption, serum phosphate, and parathyroid hormone in patients with chronic renal failure and osteodystrophy before and during hemodialysis.

Authors:  J R Juttmann; J C Hagenouw-Taal; L D Lameyer; A M Ruis; J C Birkenhäger
Journal:  Calcif Tissue Res       Date:  1978-12-08

9.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; G W Sizemore; C D Arnaud
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.